Summary
Updated Aug 31, 2026
Lori D. Lawley is Chief Financial Officer of LUMOS PHARMA, INC. (LUMO). 1 SEC Form 4 filing on record, dated 13 December 2024.
Recent Transactions
1Every recent SEC Form 4 transaction Lori D. Lawley has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Lori D. Lawley go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Lori D. Lawley's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
- Michael Simanovsky - $105.88M of SNDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lori D. Lawley?
Lori D. Lawley is a corporate insider, tracked as Chief Financial Officer of LUMOS PHARMA, INC. (LUMO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Lori D. Lawley last file a Form 4?
The only primary Form 4 on record is dated 13 December 2024.
Where can I see all of Lori D. Lawley's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lori D. Lawley and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial